Drug-related bullous fixed pigmented erythema related to the use of ivermectin in a patient with SARS-Cov2 pneumonia: Case Report

Descripción del Articulo

Background: Bullous fixed pigmented erythema is a potentially serious form of toxicoderma. It is characterized by the appearance of cutaneous and / or mucosal lesions, single or multiple, which can appear in any area, after the administration of a drug or other substance. A 73-year-old man is presen...

Descripción completa

Detalles Bibliográficos
Autores: Aguilar-Urbina, Edi William, Plasencia-Meza, Carlos, Chávez-Rimarachin, Manuel, Aquino-Salverredy, Regina, Velásquez-Ojeda, Anghelo
Formato: artículo
Fecha de Publicación:2021
Institución:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Repositorio:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
Lenguaje:español
OAI Identifier:oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/1280
Enlace del recurso:https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1280
Nivel de acceso:acceso abierto
Materia:Eritema fijo pigmentado ampolloso
toxicodermia
eritema pigmentario medicamentoso
Bullous pigmented fixed erythema
toxicoderma
drug erythema pigmentation
id REVCMH_c7798b2aa60890b110f5c3d3b212e922
oai_identifier_str oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/1280
network_acronym_str REVCMH
network_name_str Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
repository_id_str
spelling Drug-related bullous fixed pigmented erythema related to the use of ivermectin in a patient with SARS-Cov2 pneumonia: Case ReportEritema pigmentado fijo ampolloso medicamentoso relacionado con el uso de ivermectina en paciente con Neumonía por SARS–Cov-2: Reporte de casoAguilar-Urbina, Edi William Plasencia-Meza, CarlosChávez-Rimarachin, Manuel Aquino-Salverredy, Regina Velásquez-Ojeda, Anghelo Eritema fijo pigmentado ampollosotoxicodermiaeritema pigmentario medicamentosoBullous pigmented fixed erythematoxicodermadrug erythema pigmentationBackground: Bullous fixed pigmented erythema is a potentially serious form of toxicoderma. It is characterized by the appearance of cutaneous and / or mucosal lesions, single or multiple, which can appear in any area, after the administration of a drug or other substance. A 73-year-old man is presented with a diagnosis of bullous fixed pigmented erythema secondary to the ingestion of ivermectin. It is necessary for the physician to recognize the adverse effects of self-medication with ivermectin against SARS CoV-2, to make an early diagnosis and initiate timely treatment.Introducción: El eritema pigmentado fijo ampolloso, es una forma de toxicodermia potencialmente grave. Se caracteriza por la aparición de lesiones cutáneas y/o mucosas, únicas o múltiples, pueden aparecer en cualquier zona, tras la administración de un fármaco u otra sustancia. Se presenta un varón de 73 años con diagnóstico de eritema pigmentado fijo ampolloso secundario a la ingesta de ivermectina. Es necesario que el medico sepa reconocer los efectos adversos de la automedicación con ivermectina contra el SARS CoV-2, a fin de realizar un diagnóstico temprano e iniciar un tratamiento oportuno.Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo2021-12-16info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/128010.35434/rcmhnaaa.2021.143.1280Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 14 No. 3 (2021): July - September; 394 - 397Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 14 Núm. 3 (2021): Julio - Setiembre; 394 - 3972227-47312225-510910.35434/rcmhnaaa.2021.143reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstacron:HNAAAspahttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1280/515Derechos de autor 2021 Edi William Aguilar-Urbina, Carlos Plasencia-Meza, Manuel Chávez-Rimarachinhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/12802022-02-02T18:46:57Z
dc.title.none.fl_str_mv Drug-related bullous fixed pigmented erythema related to the use of ivermectin in a patient with SARS-Cov2 pneumonia: Case Report
Eritema pigmentado fijo ampolloso medicamentoso relacionado con el uso de ivermectina en paciente con Neumonía por SARS–Cov-2: Reporte de caso
title Drug-related bullous fixed pigmented erythema related to the use of ivermectin in a patient with SARS-Cov2 pneumonia: Case Report
spellingShingle Drug-related bullous fixed pigmented erythema related to the use of ivermectin in a patient with SARS-Cov2 pneumonia: Case Report
Aguilar-Urbina, Edi William
Eritema fijo pigmentado ampolloso
toxicodermia
eritema pigmentario medicamentoso
Bullous pigmented fixed erythema
toxicoderma
drug erythema pigmentation
title_short Drug-related bullous fixed pigmented erythema related to the use of ivermectin in a patient with SARS-Cov2 pneumonia: Case Report
title_full Drug-related bullous fixed pigmented erythema related to the use of ivermectin in a patient with SARS-Cov2 pneumonia: Case Report
title_fullStr Drug-related bullous fixed pigmented erythema related to the use of ivermectin in a patient with SARS-Cov2 pneumonia: Case Report
title_full_unstemmed Drug-related bullous fixed pigmented erythema related to the use of ivermectin in a patient with SARS-Cov2 pneumonia: Case Report
title_sort Drug-related bullous fixed pigmented erythema related to the use of ivermectin in a patient with SARS-Cov2 pneumonia: Case Report
dc.creator.none.fl_str_mv Aguilar-Urbina, Edi William
Plasencia-Meza, Carlos
Chávez-Rimarachin, Manuel
Aquino-Salverredy, Regina
Velásquez-Ojeda, Anghelo
author Aguilar-Urbina, Edi William
author_facet Aguilar-Urbina, Edi William
Plasencia-Meza, Carlos
Chávez-Rimarachin, Manuel
Aquino-Salverredy, Regina
Velásquez-Ojeda, Anghelo
author_role author
author2 Plasencia-Meza, Carlos
Chávez-Rimarachin, Manuel
Aquino-Salverredy, Regina
Velásquez-Ojeda, Anghelo
author2_role author
author
author
author
dc.subject.none.fl_str_mv Eritema fijo pigmentado ampolloso
toxicodermia
eritema pigmentario medicamentoso
Bullous pigmented fixed erythema
toxicoderma
drug erythema pigmentation
topic Eritema fijo pigmentado ampolloso
toxicodermia
eritema pigmentario medicamentoso
Bullous pigmented fixed erythema
toxicoderma
drug erythema pigmentation
description Background: Bullous fixed pigmented erythema is a potentially serious form of toxicoderma. It is characterized by the appearance of cutaneous and / or mucosal lesions, single or multiple, which can appear in any area, after the administration of a drug or other substance. A 73-year-old man is presented with a diagnosis of bullous fixed pigmented erythema secondary to the ingestion of ivermectin. It is necessary for the physician to recognize the adverse effects of self-medication with ivermectin against SARS CoV-2, to make an early diagnosis and initiate timely treatment.
publishDate 2021
dc.date.none.fl_str_mv 2021-12-16
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1280
10.35434/rcmhnaaa.2021.143.1280
url https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1280
identifier_str_mv 10.35434/rcmhnaaa.2021.143.1280
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1280/515
dc.rights.none.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo
publisher.none.fl_str_mv Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo
dc.source.none.fl_str_mv Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 14 No. 3 (2021): July - September; 394 - 397
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 14 Núm. 3 (2021): Julio - Setiembre; 394 - 397
2227-4731
2225-5109
10.35434/rcmhnaaa.2021.143
reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
instname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
instacron:HNAAA
instname_str Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
instacron_str HNAAA
institution HNAAA
reponame_str Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
collection Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1843263928206884864
score 12.672554
Drug-related bullous fixed pigmented erythema related to the use of ivermectin in a patient with SARS-Cov2 pneumonia: Case Report
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).

Ejemplares Similares